Inception Return
(8/4/2017)
|
7.46 %
|
YTD Return
|
23.64 %
|
|
NAVPS
(4/25/2024)
|
$12.91
|
Change
|
($0.38) / -2.86 %
|
|
Growth of $10,000
(As of March 31, 2024)
|
MER
|
1.93 %
|
Assets ($mil)
|
-
|
Rank (1Yr)
|
70/177
|
Std Dev (3Yr)
|
24.14 %
|
Volatility Ranking (3Yr)
|
10/10
|
RRSP Eligibility
|
Yes
|
Load
|
No Load
|
Max Front End
|
-
|
Max Back End
|
-
|
Sales Status
|
Open
|
|
Objective
The Fund’s objective is to achieve growth by investing primarily in equity securities of companies engaged in nutrition, nutraceuticals and new forms of medicines and pharmaceutical solutions.
|
Fund Manager
Ninepoint Partners LP
Portfolio Manager
Ninepoint Partners LP
Sub-Advisor
Douglas Waterson, Faircourt Asset Management Inc.
Charles Taerk, Faircourt Asset Management Inc.
|
Asset Allocation
(As of March 31, 2024)
|
Sector Allocation
(As of March 31, 2024)
|
Geographic Allocation
(As of March 31, 2024)
|
Top 10 Holdings
Name | Asset | Sector | Geographic | Percent |
Green Thumb Industries Inc | US Equity | Healthcare | United States | 17.71% |
Trulieve Cannabis Corp | US Equity | Healthcare | United States | 11.03% |
Verano Holdings Corp Cl A | US Equity | Consumer Services | United States | 9.81% |
Costco Wholesale Corp | US Equity | Consumer Services | United States | 6.32% |
Terrascend Corp | Canadian Equity | Healthcare | Canada | 5.30% |
Merck & Co Inc | US Equity | Healthcare | United States | 4.63% |
Eli Lilly and Co | US Equity | Healthcare | United States | 4.61% |
Johnson & Johnson | US Equity | Healthcare | United States | 4.32% |
Abbott Laboratories | US Equity | Healthcare | United States | 4.17% |
UnitedHealth Group Inc | US Equity | Healthcare | United States | 3.33% |
Performance Data
(As of March 31, 2024)
|
Return (%)
|
Annualized Return (%)
|
Return
|
1
Mth
|
3
Mth
|
6
Mth
|
YTD
|
1
Yr
|
3
Yr
|
5
Yr
|
10
Yr
|
Fund
|
8.01
|
23.64
|
21.48
|
23.64
|
28.60
|
-15.73
|
-6.88
|
-
|
Benchmark
|
4.14
|
6.62
|
15.26
|
6.62
|
13.96
|
9.11
|
9.96
|
7.67
|
Quartile Ranking
|
1
|
1
|
2
|
1
|
2
|
4
|
4
|
-
|
Calendar Return (%)
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
2016
|
2015
|
2014
|
Fund
|
-5.06
|
-36.93
|
-5.03
|
39.21
|
-5.69
|
17.55
|
-
|
-
|
-
|
-
|
Benchmark
|
11.75
|
-5.84
|
25.09
|
5.60
|
22.88
|
-8.89
|
9.10
|
21.08
|
-8.32
|
10.55
|
Quartile Ranking
|
4
|
4
|
4
|
2
|
4
|
1
|
-
|
-
|
-
|
-
|